ANIK — Anika Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Annual balance sheet for Anika Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	98.3	94.4	86.3	72.9	55.6
Net Total Accounts Receivable
Net Total Receivables	24.1	29.8	34.6	36	23.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	177	169	170	163	114
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	73.2	68.6	79	75	64.7
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	366	348	349	271	203
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	36.9	29.8	27.9	31.1	23.3
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	93.2	60.5	63.6	58.4	48.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	272	287	286	212	154
Total Liabilities & Shareholders' Equity	366	348	349	271	203
Total Common Shares Outstanding